Navigation Links
Advanced Assay Technologies and Development Methods
Date:1/13/2011

LOS ANGELES, Jan. 13, 2011 /PRNewswire/ -- UBM Canon and IVD Technology are proud to add a new webinar to its webcast series on The Fundamentals of In Vitro Diagnostics.  This one-hour event will focus specifically on Advanced Assay Technologies and Development Methods and will offer an in-depth analysis and discussion from experts in the industry.  

(Logo:  http://photos.prnewswire.com/prnh/20101214/LA16070LOGO)

Various market reports and studies have concluded that the future for immunoassays is a mixed bag. In the clinical laboratory, mature assays will show moderate growth while emerging assays will fuel most of the growth in this IVD segment. However, all immunoassays will have to pass the test of medical research to demonstrate their contributions to improving patient outcomes. In this webinar event, attendees will learn more about how immunoassays, combined with DNA probe studies, will have an important place in post-genomic medicine.

This Webcast will feature presentations by Neal Siegel, PhD, Chief Scientific Officer, Sword Diagnostics; Scott Dylewski, PhD, Senior Scientist, Alverix Inc.; and Nick Gee, PhD, CEO/CSO, Innova Biosciences Ltd. The Webcast concludes with a live Q&A session moderated by Richard Park, Editor-in-Chief of IVD Technology magazine.  For more information on our speakers, click here.  

Rich Nass, Content Director for the Medical Device Media Group, stated, "All attendees will receive a copy of our special DX Directions report on Advanced Assay Technologies, giving this event a real value-added feature." This Webcast will take place on Wednesday, January 26 at 2:00 p.m. ET (1:00 p.m. CT, 11:00 a.m. PT).  There is a small registration fee to attend.  The event will be archived for six months on the IVD Technology website and UBM Canon Medical Device Media Group's webcast archive.  For more information or to register for the event, please click here.  

About UBM Canon

UBM Canon, the leading B-to-B media company dedicated exclusively to the global $3.0 trillion advanced manufacturing sector, helps support the flow of information, commerce and innovation in such sophisticated segments as medical devices and pharmaceutical development. UBM Canon also addresses cutting-edge developments in broader areas of advanced engineering design and manufacturing, and manufacturing processes and packaging. UBM Canon is part of UBM (UBM.L) a global provider of media and information services for professional B2B communities and markets.


'/>"/>
SOURCE UBM Canon
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Reportlinker Adds Advanced Drug Delivery Markets (Liposomes, Polymers and Monoclonal Antibodies)
2. CoreLab Partners Launches Advanced Imaging Application
3. Advanced Life Sciences to Explore Strategic Alternatives to Maximize Shareholder Value
4. Advanced Laser Therapy Solutions for Womens Hair Loss
5. Centocor Ortho Biotech Inc. Announces NDA Submission for Abiraterone Acetate for the Treatment of Metastatic Advanced Prostate Cancer
6. Improvements in Recurrence-Free Survival in Early Stages of Colorectal Cancer Will Limit Growth of Drug Treatment Opportunities for Advanced Disease
7. Advanced Radiology Introduces Baltimores First 1.2T High Field Open MRI
8. EGEN, Inc. Announces that Phase II Clinical Trial for Advanced Ovarian Cancer is Open for Enrollment
9. Advanced BioHealing Appoints Kevin C. OBoyle as Chief Financial Officer
10. Study Shows Novartis Drug Afinitor® Plus Hormonal Therapy Delays Disease Progression in Advanced Metastatic Breast Cancer Patients
11. New Subgroup Analysis of LUX-Lung 1 Trial Suggests Afatinib Increases Progression-Free Survival in Advanced Lung Cancer Patients More Likely to Have EGFR Mutations
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/5/2016)... -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) today ... offering of 11,027,558 shares of its common stock by ... and Goldman Sachs.  The shares are being sold to ... share. The selling stockholders will receive all of the ... of its directors, officers or other stockholders is selling ...
(Date:2/5/2016)... 2016  Henry Schein, Inc. (NASDAQ: HSIC ), the ... to office-based dental, animal health and medical practitioners, announced ... acquire a majority ownership interest in Dental Cremer S.A., ... Brazil . --> ... is the dental distribution business of Cremer S.A. With ...
(Date:2/5/2016)... France , Germany ... and Israel ). It includes a 10-year epidemiology forecast ... segmented by age and sex in these markets. GD epidemiology report is ... in-depth, high quality, transparent and market-driven, providing expert analysis of disease trends ... Germany , Italy , Spain ...
Breaking Medicine Technology:
(Date:2/7/2016)... ... February 07, 2016 , ... Dr. Todd Hobgood , ... medical and surgical expertise. Technically known as deoxycholic acid or previously as ATX-101, ... non-surgical alternative for reduction of fat below the chin (aka the “double chin”). ...
(Date:2/6/2016)... San Rafael, CA (PRWEB) , ... February 06, 2016 , ... ... 2016 Youth Ultimate Coaching Conference (YUCC) . This event brings together top non-profit leaders, ... is “Gender Equity and Girls Ultimate”. Valerio Iani, Bay Area Disc Program Director of ...
(Date:2/6/2016)... St. Petersburg, FL (PRWEB) , ... February 06, 2016 , ... ... AsSeenOnTV.pro are pleased to announce the launch of a new DRTV campaign with Belly ... rug. If having tried everything from sprays to puppy pads and find nothing works, ...
(Date:2/5/2016)... ... ... Steven Tonkinson, 36, of Coconut Grove, Florida, ran the Miami Marathon on ... This year, he ran all 26.2 miles with a green 25-pound ShelterBox strapped to ... , This Sunday, while many are watching the Superbowl, Steven Tonkinson will strap on ...
(Date:2/5/2016)... ... February 05, 2016 , ... VeloReality President ... next generation LYNX VR Indoor Trainer with multi-rider capability to an enthusiastic audience ... not only reduce the weight of the unit, they also enhance the rider's ...
Breaking Medicine News(10 mins):